18+

 

Number №2, 2025 - page 16-20

Prevention of postcoital cystitis DOI: 10.29188/2222-8543-2025-18-2-16-20

For citation: Neimark A.I., Razdorskaya M.V., Neimark B.A., Nozdrachev N.A., Rukin R.O. Prevention of postcoital cystitis. Experimental and Clinical Urology 2025;18(2):16-20; https://doi.org/10.29188/2222-8543-2025-18-2-16-20
Neimark A.I., Razdorskaya M.V., Neimark B.A., Nozdrachev N.A., Rukin R.O.
Information about authors:
  • Neymark A.I. – Dr. Sci., Professor, Head of the Department of Urology and Andrology, Altai State Medical University, Barnaul, Russia; RSCI Author ID 527832, https://orcid.org/0000-0002-5741-6408
  • Razdorskaya M.V. – Dr. Sci., Russian Railways Medicine Hospital, Barnaul, Russia; RSCI Author ID 425652, https://orcid.org/0000-0001-8980-7764
  • Neymark B.A. – Dr. Sci., Professor, Professor of the Department of Urology and Andrology, Altai State Medical University, Barnaul, Russia; RSCI Author ID 737759, https://orcid.org/0000-0001-8009-3777
  • Nozdrachev N.A. – PhD, Associate Professor of the Department of Urology and Andrology, Altai State Medical University, Barnaul, Russia, RSCI Author ID 648075
  • Rukin R.O. – Altai State Medical University, Barnaul, Russia
309

Introduction. Postcoital cystitis, which has a chronic form, can be attributed to a type of chronic cystitis in women. In the absence of positive dynamics from behavioral therapy, herbal and antimicrobial drugs used before or after sexual intercourse to prevent exacerbation of postcoital cystitis, the priority is the use of complexes of substances that strengthen the immune system, improve the condition of the bladder mucosa and have an antimicrobial effect.

Objective: to evaluate the efficacy and safety of the drug Nephronerei for the prevention of postcoital cystitis in women.

Materials and methods. The study included 80 women with chronic postcoital cystitis, who were divided into two groups of 40 people depending on the treatment received: group – patients took Nephronerey once, 1 sachet after each sexual intercourse, and group 2 – patients took only herbal uroseptics. The observation period was 180 days.

Results. It was found that the use of Nephronerey (1 sachet after each sexual contact) for six months significantly reduces the likelihood of relapses, reducing them threefold. Good tolerability of the drug, a noticeable decrease in the frequency of exacerbations and, as a result, a significant improvement in the quality of life of patients were noted.

Conclusions. The drug Nephronerey can be recommended for the prevention of postcoital cystitis.

AttachmentSize
Download1.28 MB
postcoital cystitis; Nephronerey; D-mannose; vitamin D; cranberry extract

Readera - Социальная платформа публикаций

Crossref makes research outputs easy to find, cite, link, and assess